Boosting-Dose Ritonavir Does Not Alter Peripheral Insulin Sensitivity in Healthy, HIVSeronegative Volunteers

BACKGROUND: Some HIV protease inhibitors (PI), including full dose ritonavir (800 mg) and ritonavir-boosted lopinavir, acutely induce insulin resistance in the absence of HIV infection and changes in body composition. Boosting-dose ritonavir (100 to 200 mg) is the most commonly prescribed PI, yet it...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: TAYLOR, Steven A., LEE, Grace A., PAO, Vivian Y., ANTHONYPILLAI, Jayaranjan, AWEEKA, Francesca T., SCHWARZ, Jean-Marc, MULLIGAN, Kathleen, SCHAMBELAN, Morris, GRUNFELD, Carl
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3164483/
https://ncbi.nlm.nih.gov/pubmed/20595906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3181e6a7d9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados